Lista de obras - Joep Lange - Dominio Público Uruguay

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy

artículo científico publicado en 2009

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

artículo científico publicado en 2003

CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater

artículo científico publicado en 2007

Does highly active antiretroviral therapy induce sickle cell crises?

scientific article published on 01 July 2002

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

artículo científico publicado en 2005

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria

artículo científico publicado en 2013

Global threat from drug resistant HIV in sub-Saharan Africa

artículo científico publicado en 2012

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries

artículo científico publicado en 2007

Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.

artículo científico publicado en 2004

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

artículo científico publicado en 2004

No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations

artículo científico publicado en 2006

Safety and efficacy of once-daily nevirapine dosing: a multicohort study

artículo científico publicado en 2009

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

artículo científico publicado en 2005

Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen

artículo científico publicado en 2007

State of affairs of tuberculosis in prison facilities: a systematic review of screening practices and recommendations for best TB control

artículo científico publicado en 2013

Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES).

artículo científico publicado en 2007

TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

artículo científico

The development of artificial neural networks to predict virological response to combination HIV therapy.

artículo científico publicado en 2007

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic

artículo científico publicado en 2008

Time to act: global apathy towards HIV/AIDS is a crime against humanity

artículo científico publicado en 2002

Treatment as prevention--where next?

artículo científico publicado en 2014

Viral replication under combination antiretroviral therapy: a comparison of four different regimens

artículo científico publicado en 2002

Lista de obras de Joep Lange

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater

Does highly active antiretroviral therapy induce sickle cell crises?

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria

Global threat from drug resistant HIV in sub-Saharan Africa

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries

Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations

Safety and efficacy of once-daily nevirapine dosing: a multicohort study

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen

State of affairs of tuberculosis in prison facilities: a systematic review of screening practices and recommendations for best TB control

Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES).

TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

The development of artificial neural networks to predict virological response to combination HIV therapy.

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic

Time to act: global apathy towards HIV/AIDS is a crime against humanity

Treatment as prevention--where next?

Viral replication under combination antiretroviral therapy: a comparison of four different regimens